Day One Biopharmaceuticals Ownership | Who Owns Day One Biopharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Day One Biopharmaceuticals Ownership Summary


Day One Biopharmaceuticals is owned by 83.57% institutional investors, 16.87% insiders. Fmr is the largest institutional shareholder, holding 13.34% of DAWN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.43% of its assets in Day One Biopharmaceuticals shares.

DAWN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDay One Biopharmaceuticals83.57%16.87%-0.44%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 307.00%11.11%-218.12%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr12.89M13.34%$163.28M
Blackrock funding, inc. /de9.83M9.54%$63.90M
Atlas venture life science advisors6.43M6.24%$41.80M
Vanguard group5.85M6.05%$74.11M
Blackrock4.53M5.23%$62.47M
Franklin resources3.88M4.02%$49.20M
Deerfield management company, l.p. (series c)3.72M3.61%$24.20M
Pictet asset management sa3.72M3.61%$24.20M
State street3.10M3.21%$39.30M
Alyeska investment group3.01M2.92%$19.58M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Atlas venture life science advisors6.43M6.31%$41.80M
Stonepine capital management450.00K2.87%$2.92M
Dafna capital management879.16K1.58%$5.71M
Vestal point capital, lp3.00M1.03%$19.50M
Boxer capital1.19M0.86%$16.40M
Braidwell lp2.18M0.48%$14.18M
Deerfield management company, l.p. (series c)3.72M0.44%$24.20M
Ecor1 capital862.07K0.41%$10.92M
Parkman healthcare partners500.00K0.37%$3.25M
Sphera funds management175.37K0.27%$1.14M

Top Buyers

HolderShares% AssetsChange
Fmr12.89M0.01%5.48M
Blackrock funding, inc. /de9.83M0.00%3.07M
Deerfield management company, l.p. (series c)3.72M0.44%762.39K
Qube research944.20K0.01%663.42K
J. goldman & co lp557.48K0.09%557.48K

Top Sellers

HolderShares% AssetsChange
Ra capital management---5.76M
Estuary capital management lp---3.33M
Fairmount funds management---3.10M
Viking global investors lp---2.56M
Maverick capital---2.11M

New Positions

HolderShares% AssetsChangeValue
J. goldman & co lp557.48K0.09%557.48K$3.62M
Point72 asset management391.28K0.01%391.28K$2.54M
Y-intercept (hong kong)281.53K0.04%281.53K$1.83M
Schroder investment management group180.13K0.00%180.13K$1.17M
Norges bank169.00K0.00%169.00K$2.14M

Sold Out

HolderChange
Pnc financial services group-3.00
True wealth design-4.00
Srs capital advisors-8.00
Nelson, van denburg & campbell wealth management group-12.00
Northwestern mutual wealth management-14.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025178-6.32%86,133,5140.67%831.20%101-6.48%5210.64%
Mar 31, 202519311.56%94,051,9090.33%910.97%10813.68%4720.51%
Dec 31, 2024170-3.41%93,046,5121.26%961.06%93-8.82%408.11%
Sep 30, 20241746.10%91,763,45623.09%941.30%10227.50%37-22.92%
Jun 30, 202416310.14%74,549,9372.96%861.04%8011.11%479.30%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.46M2.43%522.40K
Vanguard Total Stock Mkt Idx Inv2.39M2.33%-52.94K
Pictet-Biotech P USD2.25M2.19%27.52K
Polar Capital Biotech S Inc2.11M2.06%-
iShares Russell 2000 ETF1.66M1.62%-31.61K
Franklin Small Cap Growth SMA1.61M1.59%1.61M
Franklin US Small Cap Growth Equity1.61M1.59%130.60K
Fidelity Small Cap Growth1.59M1.57%-4.22K
Franklin Biotechnology Discv A(acc)USD1.55M1.52%-
Franklin Small Cap Growth Adv1.48M1.45%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 18, 2025York Charles N II COO and CFOSell$27.79K
Aug 18, 2025Dubow Adam Gen Counsel & SecretarySell$29.54K
Aug 18, 2025Bender Jeremy CHIEF EXECUTIVE OFFICERSell$108.67K
Aug 18, 2025Merendino Lauren Chief Commercial OfficerSell$25.48K
May 16, 2025Merendino Lauren Chief Commercial OfficerSell$24.57K

Insider Transactions Trends


DateBuySell
2025 Q3-4
2025 Q2-4
2025 Q1-3
2024 Q4-9
2024 Q316

DAWN Ownership FAQ


Who Owns Day One Biopharmaceuticals?

Day One Biopharmaceuticals shareholders are primarily institutional investors at 83.57%, followed by 16.87% insiders and -0.44% retail investors. The average institutional ownership in Day One Biopharmaceuticals's industry, Biotech Stocks , is 307.00%, which Day One Biopharmaceuticals falls below.

Who owns the most shares of Day One Biopharmaceuticals?

Day One Biopharmaceuticals’s largest shareholders are Fmr (12.89M shares, 13.34%), Blackrock funding, inc. /de (9.83M shares, 9.54%), and Atlas venture life science advisors (6.43M shares, 6.24%). Together, they hold 29.11% of Day One Biopharmaceuticals’s total shares outstanding.

Does Blackrock own Day One Biopharmaceuticals?

Yes, BlackRock owns 5.23% of Day One Biopharmaceuticals, totaling 4.53M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 62.47M$. In the last quarter, BlackRock decreased its holdings by -498K shares, a -9.90% change.

Who is Day One Biopharmaceuticals’s biggest shareholder by percentage of total assets invested?

Atlas venture life science advisors is Day One Biopharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.31% of its assets in 6.43M Day One Biopharmaceuticals shares, valued at 41.8M$.

Who is the top mutual fund holder of Day One Biopharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Day One Biopharmaceuticals shares, with 2.43% of its total shares outstanding invested in 2.46M Day One Biopharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools